[{"id":"202a63d1-07ad-43e6-b0e5-90f62602468d","acronym":"","url":"https://clinicaltrials.gov/study/NCT04149613","created_at":"2021-01-18T20:15:40.071Z","updated_at":"2024-07-02T16:36:07.094Z","phase":"","brief_title":"Predictive and Prognostic Value of Inflammatory Markers and microRNA in Stage IV Colorectal Cancer","source_id_and_acronym":"NCT04149613","lead_sponsor":"American University of Beirut Medical Center","biomarkers":" MIR155 • MIR200B • MIR21 • MIR200C • MIR126 • MIR210 • MIR31 • CRP • MIR19A • MIR203A • MIR29A • MIR345","pipe":"","alterations":" ","tags":["MIR155 • MIR200B • MIR21 • MIR200C • MIR126 • MIR210 • MIR31 • CRP • MIR19A • MIR203A • MIR29A • MIR345"],"overall_status":"Enrolling by invitation","enrollment":" Enrollment 100","initiation":"Initiation: 05/25/2018","start_date":" 05/25/2018","primary_txt":" Primary completion: 12/18/2023","primary_completion_date":" 12/18/2023","study_txt":" Completion: 04/18/2024","study_completion_date":" 04/18/2024","last_update_posted":"2022-07-20"},{"id":"bef2d1de-fe6b-4a1a-afd6-2e7ba2b0ef48","acronym":"","url":"https://clinicaltrials.gov/study/NCT01281124","created_at":"2021-05-21T18:52:45.139Z","updated_at":"2024-07-02T16:36:55.287Z","phase":"Phase 2","brief_title":"Azacitidine in Treating Patients With Previously Treated Advanced Non-Small Cell Lung Cancer","source_id_and_acronym":"NCT01281124","lead_sponsor":"National Cancer Institute (NCI)","biomarkers":" MIR29A","pipe":"","alterations":" ","tags":["MIR29A"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e azacitidine"],"overall_status":"Completed","enrollment":" Enrollment 1","initiation":"Initiation: 01/12/2011","start_date":" 01/12/2011","primary_txt":" Primary completion: 04/15/2011","primary_completion_date":" 04/15/2011","study_txt":" Completion: 09/12/2012","study_completion_date":" 09/12/2012","last_update_posted":"2019-09-24"}]